Similar articles

• Clinical and immunological aspects of liver allograft rejection.

  Schlitt HJ. Schlitt HJ. Transplant Proc. 1996 Feb;28(1):514-6. Transplant Proc. 1996. PMID: 8644333 Review. No abstract available.
• Incidence and outcome of OKT3 treatment for early steroid-resistant rejection following hepatic transplantation.

  Lange D, Bechstein WO, Blumhardt G, Lemmens P, Schattenfroh N, Neuhaus P. Lange D, et al. Transplant Proc. 1993 Apr;25(2):1870-1. Transplant Proc. 1993. PMID: 8470207 Clinical Trial. No abstract available.
• FK 506 used as rescue therapy for refractory liver allograft rejection.

  Chen CL, Eng HL, Chen YS, Kuo YC, Sun CK. Chen CL, et al. Transplant Proc. 1994 Aug;26(4):1927-9. Transplant Proc. 1994. PMID: 7520612 No abstract available.
• Treatment of steroid-resistant rejection with tacrolimus prior to OKT3 in liver transplant recipients.

  Millis JM, Bruce DS, Newell KA, Piper JB, Woodle ES, Seaman DS, Baker AL, Hart J, Dasgupta K, Thistlethwaite JR Jr. Millis JM, et al. Transplant Proc. 1996 Apr;28(2):1014. Transplant Proc. 1996. PMID: 8623213 No abstract available.
• Treatment of liver allograft rejection.

  Millis JM. Millis JM. Liver Transpl Surg. 1999 Jul;5(4 Suppl 1):S98-S106. doi: 10.1053/JTLS005s00098. Liver Transpl Surg. 1999. PMID: 10431023 Review. No abstract available.